This is a news story, published by torontosun, that relates primarily to Bill Traynor news.
For more Bill Traynor news, you can click here:
more Bill Traynor newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from torontosun, you can click here:
more news from torontosunOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
ALS diagnosis. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest ALS patients news, ALS clinic news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
first ALS patienttorontosun
•Health
Health
74% Informative
Bill Traynor , 70 , is the world’s first ALS patient to receive a drug this way.
Traynor is the first of six patients in a Phase 1 clinical trial to determine the safety of administering drugs through non-invasive ultrasound waves to ALS patients.
The blood-brain barrier is there to protect us, so it keeps viruses, bacteria and toxins out of the brain.
Researchers will be looking for biomarkers of inflammation in Bill Traynor ’s blood and cerebrospinal fluid.
They’ve cautioned Traynor that this trial is not expected to result in any form of treatment.
But Traynor still sees the study as a source of hope, calling it “exciting to be a guinea pig”.
VR Score
70
Informative language
67
Neutral language
18
Article tone
informal
Language
English
Language complexity
44
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
5
Affiliate links
no affiliate links
